The results of this retrospective study of 207 advanced NSCLC patients treated with platinum-doublet chemotherapy in the first-line setting with at least two cycles, demonstrate that female gender, squamous cell carcinoma histology, and normal pre-treatment serum albumin are positive predictive factors for chemotherapy response. This evidence concerns the gene ALB and non-small cell lung carcinoma.